Papers
8
Total Citations
265
H-Index
5
About
A. Karim Kader is a leading urologic oncologist whose research has fundamentally advanced the surgical management of bladder cancer, particularly through the adoption and validation of robotic-assisted techniques. His major contributions center on demonstrating the safety, efficacy, and comparative advantages of robot-assisted radical cystectomy (RARC) over traditional open surgery. In a landmark study of 200 patients (cited over 100 times), Kader showed that RARC offers comparable oncological outcomes with significantly fewer complications. He further established that robotic pelvic lymphadenectomy rivals the thoroughness of open surgery and that elderly patients, often deemed high-risk, benefit substantially from the minimally invasive approach. As a key contributor to the International Robotic Cystectomy Consortium, Kader helped generate multi-institutional evidence on pathologic and early oncologic outcomes, as well as the critical comparison of intra-corporeal versus extra-corporeal urinary diversion. His work has been instrumental in shifting the standard of care, proving that robotic surgery is not merely an alternative but a justified, often superior, option for patients with bladder cancer.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5Robotic Radical Cystectomy: Where are We Today, Where will We be Tomorrow?11 citations · 2010
- 6
- 7
- 8